image
Assembly Biosciences, Inc. ASMB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 16.14
-5.34 %
$ 103 M
Market Cap
-1.86
P/E
BALANCE SHEET
137 M ASSETS
35.05%
Growth Rates
1Year 35.05%
3Years -21.41%
5Years -12.50%
7Years 4.94%
10Years 17.62%
96.4 M LIABILITIES
403.77%
Growth Rates
1Year 403.77%
3Years 31.20%
5Years 10.92%
7Years 26.84%
10Years 43.31%
41.1 M EQUITY
-50.28%
Growth Rates
1Year -50.28%
3Years -44.51%
5Years -27.88%
7Years -9.06%
10Years 5.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Assembly Biosciences, Inc.
image
Current Assets 134 M
Cash & Short-Term Investments 130 M
Receivables 43 K
Other Current Assets 3.5 M
Non-Current Assets 3.68 M
Long-Term Investments 0
PP&E 2.72 M
Other Non-Current Assets 958 K
Current Liabilities 39.2 M
Accounts Payable 461 K
Short-Term Debt 1.22 M
Other Current Liabilities 37.5 M
Non-Current Liabilities 57.1 M
Long-Term Debt 1.12 M
Other Non-Current Liabilities 56 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 19.8 52.4 45.6 59.4 46.7 41.5 82.0 28.6 27.1 29.1 27.1 20.5 37.0 14.6 81.3 K 15.9 K
Short Term Investments 110.4 39.2 101.0 157.0 227.3 176.6 37.9 24.4 40.6 0 0 0 0 0 0 0
Receivables 43 K 0.9 0.3 1.2 3.4 2.4 2.3 0 0 0 0 0 0 0 0 0
Inventory 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0
Other Current Assets 6.7 4.4 14.5 13.7 10.7 4.0 0.9 0.6 0.7 0.1 63.7 K 59.6 K 62.1 K 18.9 K 2.52 K 0.8
Total Current Assets 133.8 97.0 154.2 224.5 282.8 222.5 123.1 53.6 68.4 29.2 27.1 20.5 37.0 14.6 83.8 K 0.8
PP&E 2.7 3.9 7.2 10.7 13.8 0.6 0.9 0.2 0.1 0.2 7.1 K 6.84 K 8.22 K 0 12.5 K 17.5 K
Intangible Assets 0 0 0 29.0 29.0 29.0 29.0 29.0 29.0 29.0 0 0 0 0 0 0
Goodwill 0 0 0 12.6 12.6 12.6 12.6 12.6 12.6 12.7 0 0 0 0 0 0
Long Term Investments 0 0 28.0 (7.3) (8.0) 0 3.3 2.4 23.4 0 0 0 0 0 0 0
Other Long Term Assets 0.3 78 K 1.7 6.4 1.7 3.3 0.3 0.3 0.2 0.1 0 0 0 26.6 K 69.9 K 31.9 K
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 137.5 101.8 191.1 283.3 339.9 268.0 169.3 98.1 133.7 71.2 27.1 20.6 37.0 14.6 0.2 0.9
LIABILITIES
Accounts Payable 0.5 2.5 2.7 4.6 1.7 3.7 2.1 2.4 1.4 0.9 2.6 1.8 2.3 0.3 0.4 4.1
Short Term Debt 1.2 6.7 6.3 6.8 6.4 0 0 0 0 0 0 0 0 1.2 7.8 0.2
Other Current Liabilities 6.6 7.1 7.1 13.0 9.9 9.7 11.4 4.8 2.0 0.1 23.4 K 0.9 0.2 0.2 4.1 0.4
Total Current Liabilities 39.2 16.3 16.1 24.4 24.4 18.5 13.5 7.1 3.4 1.1 2.6 2.7 2.5 1.7 12.4 4.7
Long Term Debt 1.1 0.1 3.3 6.7 9.1 0 0 0 0 0 0 0 0 1.3 1.2 5.6
Deferred Tax Income 0.6 (2.7) (2.7) 2.5 2.5 3.3 2.1 11.1 11.6 11.6 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0
Total Liabilities 96.4 19.1 22.1 42.7 66.7 57.4 56.2 18.2 15.0 12.7 2.6 2.7 2.5 3.0 13.5 10.3
EQUITY
Common Stock 5 K 49 K 48 K 34 K 32 K 25 K 20.1 K 17.2 K 17.2 K 10.7 K 20.7 K 12.9 K 12.4 K 6.75 K 447 445
Retained Earnings (785.7) (724.5) (631.4) (501.6) (439.4) (341.8) (251.0) (208.2) (164.0) (135.5) (111.7) (92.3) (67.5) (33.2) (17.9) (13.4)
Other Accumulative Comprehensive Income/Loss 81 K (0.8) (0.4) (0.3) (0.2) (0.3) (0.4) (0.6) (0.8) 0 39.3 K 33 K 28.4 K 27.3 K 14.7 K 7.22 K
Total Equity 41.1 82.7 168.9 240.6 273.2 210.7 113.1 79.9 118.7 58.6 24.5 17.8 34.5 11.6 (13.4) (9.5)
Total Liabilities and Equity 137.5 101.8 191.1 283.3 339.9 268.0 169.3 98.1 133.7 71.2 27.1 20.6 37.0 14.6 0.2 0.9
SHARES OUTSTANDING
Common Shares Outstanding 4.6 4.0 46.5 39.7 35.1 22.8 17.8 17.2 15.7 7.0 3.9 2.5 1.9 0.1 89 K 84.3 K